Mohammad Ali Navabi Shirazi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Ali Navabi Shirazi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Sedaghat
Department of Pediatric Cardiology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Alireza Dehestani
Department of Pediatric Cardiac Surgery, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Aliyeh Nikdoost
Department of Pediatric Cardiology, Payambar Azam Hospital, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Fateme Tabrizi
Department of Biology, Yazd University, Yazd, Iran
1 shared publication - Hasan Tatari
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - José Bragança
Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, 8005-139 Faro, Portugal
1 shared publication
Latest Publications
- 29 March 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-14
Novel and deleterious nucleotide variations in the HAND1 gene probably affect miRNA target sites and protein function in pediatric patients with congenital heart disease
Background Congenital heart disease (CHD) is the most prevalent developmental defect and principal cause of infant mortality and affects cardiac and large blood vessel structures in approximately 1% of live births worldwide. To date, numerous studies have related critical genetic dysfunctions to the pathogenesis of CHDs. However, the genetic basis underlying CHD remains largely unknown. In the present study, we investigated the association of nucleotide variations in coding and noncoding regions of the HAND1 gene with the risk of CHD. The HAND1 gene, encoding a helix-loop-helix transcription factor, is particularly relevant for mechanisms underlying CHD since it plays a significant role in heart development. Methods and results The genomic DNA of 150 unrelated pediatric patients with CHD was screened by PCR-SSCP and direct sequencing. Four novel and heterozygous missense mutations were identified in the first exon, with three causing amino acid substitutions (p.Val149Met, p.Tyr142His, and p.Leu146Met). In-silico analysis also indicated their deleterious impact on protein structure and function. In addition, we identified five novel nucleotide variants in the 3′UTR region (c.*461, c.*342, c.*529, c.*448, c.*593), potentially altering the target sites of miRNAs. These changes include the loss of certain target sites and the acquisition of new ones. Conclusions These findings confirm the phenotypic association between CHDs and HAND1 mutations and can pave the way for developing new preventive and therapeutic strategies.
- 29 March 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-14
Novel and deleterious nucleotide variations in the HAND1 gene probably affect miRNA target sites and protein function in pediatric patients with congenital heart disease
Background Congenital heart disease (CHD) is the most prevalent developmental defect and principal cause of infant mortality and affects cardiac and large blood vessel structures in approximately 1% of live births worldwide. To date, numerous studies have related critical genetic dysfunctions to the pathogenesis of CHDs. However, the genetic basis underlying CHD remains largely unknown. In the present study, we investigated the association of nucleotide variations in coding and noncoding regions of the HAND1 gene with the risk of CHD. The HAND1 gene, encoding a helix-loop-helix transcription factor, is particularly relevant for mechanisms underlying CHD since it plays a significant role in heart development. Methods and results The genomic DNA of 150 unrelated pediatric patients with CHD was screened by PCR-SSCP and direct sequencing. Four novel and heterozygous missense mutations were identified in the first exon, with three causing amino acid substitutions (p.Val149Met, p.Tyr142His, and p.Leu146Met). In-silico analysis also indicated their deleterious impact on protein structure and function. In addition, we identified five novel nucleotide variants in the 3′UTR region (c.*461, c.*342, c.*529, c.*448, c.*593), potentially altering the target sites of miRNAs. These changes include the loss of certain target sites and the acquisition of new ones. Conclusions These findings confirm the phenotypic association between CHDs and HAND1 mutations and can pave the way for developing new preventive and therapeutic strategies.
- Open Access
- 1 January 2022
- Published by Korean Society of Echocardiography in Journal of Cardiovascular Imaging
- Vol. 30 (2) , 99-108
Pulsatility Index in Different Modifications of Fontan Palliation: An Echocardiographic Assessment
Shabanian R, et al. J Cardiovasc Imaging. 2021 Nov;30:e7. https://doi.org/10.4250/jcvi.2021.0133
- 1 January 2022
- Published by Korean Society of Echocardiography in Journal of Cardiovascular Imaging
- Vol. 30 (2) , 99-108
Open AccessPulsatility Index in Different Modifications of Fontan Palliation: An Echocardiographic Assessment
Shabanian R, et al. J Cardiovasc Imaging. 2021 Nov;30:e7. https://doi.org/10.4250/jcvi.2021.0133